Startup-166
Amsterdam, Netherlands
Allergios is developing an AI-powered microfluidic platform for functional allergy diagnostics.
Our goal is to replace risky oral provocation tests (e.g. DBPCFC) with an automated blood test that analyzes individual cellular immune responses to allergens. The platform integrates digital holography and cellular immunoassays, targeting the fast-growing market of clinical allergy diagnostics and research.